bioAffinity Technologies, Inc. (BIAF)
NASDAQ: BIAF · Real-Time Price · USD
0.830
+0.020 (2.47%)
Feb 21, 2025, 4:00 PM EST - Market closed
bioAffinity Technologies Employees
bioAffinity Technologies had 75 employees as of December 31, 2023. The number of employees increased by 61 or 435.71% compared to the previous year.
Employees
75
Change (1Y)
61
Growth (1Y)
435.71%
Revenue / Employee
$124,904
Profits / Employee
-$112,615
Market Cap
12.94M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 75 | 61 | 435.71% |
| Dec 31, 2022 | 14 | 3 | 27.27% |
| Dec 31, 2021 | 11 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 122,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 72,000 |
BIAF News
- 4 weeks ago - bioAffinity Technologies Announces Acceptance of Patent Application for Early-Stage Lung Cancer Diagnostic - Business Wire
- 5 weeks ago - bioAffinity Technologies Reports Positive Results from Texas Beta Launch of CyPath® Lung - Business Wire
- 6 weeks ago - Enlivex Therapeutics and bioAffinity Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Accesswire
- 2 months ago - Join bioAffinity Technologies' Exclusive Live Investor Webinar and Q&A Session on Thursday, December 19 - Business Wire
- 2 months ago - bioAffinity Technologies Set for Continued Expansion in 2025 - Business Wire
- 3 months ago - bioAffinity Technologies Reports $2.4 Million Revenue for Q3 2024 - Business Wire
- 3 months ago - bioAffinity Technologies Appoints New Chief Science Officer to Spearhead Product Development - Business Wire
- 4 months ago - bioAffinity Technologies Announces Award of Japanese Patent for CyPath® Lung - Business Wire